AVANTOR INC

NYSE: AVTR (Avantor, Inc.)

Kemas kini terakhir: 28 Nov, 12:06AM

11.74

-0.11 (-0.93%)

Penutupan Terdahulu 11.85
Buka 11.76
Jumlah Dagangan 6,485,740
Purata Dagangan (3B) 10,404,971
Modal Pasaran 8,004,506,112
Harga / Pendapatan (P/E Ke hadapan) 12.30
Harga / Jualan (P/S) 1.22
Harga / Buku (P/B) 1.44
Julat 52 Minggu
10.83 (-7%) — 23.32 (98%)
Tarikh Pendapatan 29 Oct 2025
Margin Keuntungan 10.70%
Margin Operasi (TTM) 8.21%
EPS Cair (TTM) 1.04
Pertumbuhan Hasil Suku Tahunan (YOY) -5.90%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 6.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 67.34%
Nisbah Semasa (MRQ) 1.12
Aliran Tunai Operasi (OCF TTM) 808.50 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 751.08 M
Pulangan Atas Aset (ROA TTM) 3.53%
Pulangan Atas Ekuiti (ROE TTM) 12.52%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Menaik Bercampur
Medical Instruments & Supplies (Global) Bercampur Menurun
Stok Avantor, Inc. Bercampur Menurun

AISkor Stockmoo

-1.0
Konsensus Penganalisis 3.0
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal -2.5
Osilator Teknikal -2.5
Purata -1.00

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
AVTR 8 B - - 1.44
TFX 6 B 0.26% 30.44 1.32
NVST 3 B - 232.22 1.08
ALC 39 B 0.35% 37.24 1.68
RMD 37 B 0.21% 25.64 6.10
STVN 6 B 0.21% 39.63 3.61

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 1.35%
% Dimiliki oleh Institusi 103.17%

Pemilikan

Nama Tarikh Syer Dipegang
New Mountain Capital, L.L.C. 30 Sep 2025 14,000,000
Julat 52 Minggu
10.83 (-7%) — 23.32 (98%)
Julat Harga Sasaran
12.00 (2%) — 17.00 (44%)
Tinggi 17.00 (Baird, 44.80%) Beli
Median 14.00 (19.25%)
Rendah 12.00 (JP Morgan, 2.22%) Pegang
12.00 (Barclays, 2.22%) Pegang
Purata 14.20 (20.95%)
Jumlah 3 Beli, 2 Pegang
Harga Purata @ Panggilan 12.62
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Barclays 30 Oct 2025 12.00 (2.21%) Pegang 11.05
02 Oct 2025 15.00 (27.77%) Beli 13.77
Evercore ISI Group 30 Oct 2025 14.00 (19.25%) Beli 11.05
JP Morgan 30 Oct 2025 12.00 (2.21%) Pegang 11.05
Baird 24 Oct 2025 17.00 (44.80%) Beli 15.40
Raymond James 16 Oct 2025 16.00 (36.29%) Beli 14.57

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
04 Dec 2025 Pengumuman Shareholders SueWallSt in New Class Action Against Avantor, Inc. - Act Now
04 Dec 2025 Pengumuman Avantor® Appoints Sanjeev Mehra to its Board of Directors
04 Dec 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
03 Dec 2025 Pengumuman New SueWallSt Podcast Covers Avantor, Inc. (AVTR) Class Action
02 Dec 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
02 Dec 2025 Pengumuman Avantor, Inc. (AVTR) Shareholders Get Answers in Latest SueWallSt Podcast
01 Dec 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
01 Dec 2025 Pengumuman Latest SueWallSt Podcast: What AVTR Investors Need to Know About the Lawsuit
25 Nov 2025 Pengumuman Investors SueWallSt as Avantor, Inc. Faces Securities Fraud Allegations
25 Nov 2025 Pengumuman Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology
25 Nov 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
24 Nov 2025 Pengumuman Investors SueWallSt as Avantor, Inc. Faces Securities Fraud Allegations
24 Nov 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
20 Nov 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
19 Nov 2025 Pengumuman Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility
18 Nov 2025 Pengumuman Investors SueWallSt as Avantor, Inc. Faces Securities Fraud Allegations
18 Nov 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
17 Nov 2025 Pengumuman Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
12 Nov 2025 Pengumuman Shareholders SueWallSt in New Class Action Against Avantor, Inc. - Act Now
10 Nov 2025 Pengumuman Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer
31 Oct 2025 Pengumuman RGRD LLP Announces a Class Action Lawsuit Has Been Filed Against Avantor, Inc. (AVTR), Encourages Investors and Potential Witnesses to Contact Firm
30 Oct 2025 Pengumuman Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies
29 Oct 2025 Pengumuman Avantor® Reports Third Quarter 2025 Results
23 Oct 2025 Pengumuman Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables
15 Oct 2025 Pengumuman Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology
13 Oct 2025 Pengumuman Avantor® Announces Board Chairman Transition
03 Oct 2025 Pengumuman Avantor® Appoints Gregory T. Lucier to its Board of Directors
01 Oct 2025 Pengumuman Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda